SC
ELV icon

Sepio Capital’s Elevance Health ELV Stock Holding History

Sepio Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-573
Closed -$201K – 384
2025
Q4 		$201K Buy
+573
New +$194K 0.01% 352
2023
Q2 		– Sell
-5,219
Closed -$2.4M – 344
2023
Q1 		$2.4M Buy
5,219
+176
+3% +$83.8K 0.22% 131
2022
Q4 		$2.59M Buy
+5,043
New +$2.56M 0.22% 115
2022
Q1 		– Sell
-9,429
Closed -$4.37M – 358
2021
Q4 		$4.37M Sell
9,429
-3,294
-26% -$1.39M 0.32% 92
2021
Q3 		$4.74M Buy
12,723
+1,818
+17% +$691K 0.39% 70
2021
Q2 		$4.16M Buy
+10,905
New +$4.17M 0.34% 83

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Sepio Capital's ELV Position: Q1 2026 in Review

Sepio Capital sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 573 shares — an estimated $201K sold.

Sepio Capital first reported a position in ELV in Q2 2021 and held it in 6 quarters. The position peaked at $4.74M in Q3 2021. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Sepio Capital reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Sepio Capital sold 573 Elevance Health shares in Q1 2026, an estimated $201K.
  • Sepio Capital first reported a position in Elevance Health in Q2 2021 and held it in 6 quarters.
  • Sepio Capital's Elevance Health position peaked at $4.74M in Q3 2021.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Sepio Capital's 13F filing for Q1 2026, filed 13 May 2026.